Tratamento e prevenção da osteorradionecrose e osteonecrose dos maxilares induzida por medicamentos: implementação do protocolo pento/pentoclo
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
Osteoradionecrosis of the jaw (ORN) and medication-related osteonecrosis of
the jaw (MRONJ) are serious complications associated with head and neck
radiotherapy and the use of antiresorptive drugs or angiogenesis inhibitors,
respectively. Recently, based on the understanding of the pathophysiology of ORN and
MRONJ, the use of drug protocols such as PENTOCLO (pentoxifylline, tocopherol, and
clodronate) and PENTO (pentoxifylline and tocopherol) for the treatment and
prevention of these conditions has been proposed. The aim of this study was to
perform a narrative review of the literature on the use of the PENTO/PENTOCLO
protocol in the treatment and prevention of ORN and MRONJ. Retrospective,
prospective, randomized clinical studies and case series reports published between
2010 and 2023 were included. The databases used for the search were PubMed,
SciELO, Elsevier, and Biblioteca Virtual em Saúde, focusing on articles in English and
Portuguese. Simple literature reviews and case reports were excluded. It is concluded
that the PENTO/PENTOCLO protocol appears as a promising option, characterized by
its simplicity and accessibility in treatment. Despite the positive preliminary results, it
is essential to carry out additional studies, especially multicenter ones, for the definitive
validation of the protocol and its large-scale implementation in health services.
Description
Keywords
Osteorradionecrose , Osteonecrose , Pento , Pentoclo , Tratamento , Osteoradionecrosis , Osteonecrosis , Pento , Pentoclo , Treatment
Citation
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

